Utah Medical Products Inc (UTMD)

Utah Medical Products, Inc. is a healthcare equipment company that develops and supplies medical devices for use in hospitals, clinics, and physician practices worldwide. Its product range includes fetal monitoring accessories, vacuum-assisted delivery systems, labor and delivery tools, infant respiratory hoods, blood pressure monitoring systems, and a variety of catheterization and pressure monitoring products. The company also offers gynecologic and laparoscopic instruments, electrosurgical devices, female surgical contraception products, urinary incontinence systems, and related disposable accessories and components. Utah Medical Products serves neonatal intensive care units, labor and delivery departments, women’s health centers, outpatient clinics, and physician offices. Incorporated in 1978, the company is headquartered in Midvale, Utah, and its common stock is listed on the NASDAQ under the symbol UTMD.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-UTMD
$77.22
4.4% Upside
Fair
Not available
Not available
Great
October 5, 2026
1.7%
October 23, 2026
22.5x
1.9x
6.5x
235.4 M
148.9 M
0.1%
87.3%
59.2
37.6%
109.2%
Valuation • Fair Value

Utah Medical Products Inc (NASDAQ-UTMD) Fair Value by Valuation Model

Review the available estimates for Utah Medical Products Inc (NASDAQ-UTMD), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$77.22

Estimated upside of 4.4% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$81.99

Discounted cash flow valuation reference.

Ben Graham Formula Value

$36.55

Classic Ben Graham valuation formula reference.

DDM Fair Value

$87.12

Dividend discount model valuation reference.

EPV Fair Value

$70.90

Earnings power value estimate.

Comps Fair Value

$70.21

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 7 available valuation references for Utah Medical Products Inc (NASDAQ-UTMD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Utah Medical Products Inc (NASDAQ-UTMD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

36.109 M

Current operating scale indicator.

Revenue Forecast

38.52 M

Forward revenue estimate.

EBITDA

14.369 M

Current operating profitability reference.

EBITDA Forecast

16.644 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Utah Medical Products Inc (NASDAQ-UTMD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Utah Medical Products Inc (NASDAQ-UTMD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.58

No elevated caution signal from this screen.

Altman Z-Score

59.2

Relatively strong balance-sheet zone.

FCF / Net Income

109.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Utah Medical Products Inc (NASDAQ-UTMD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Utah Medical Products Inc (NASDAQ-UTMD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 23, 2026

Days to Earnings

35

Dividend Payment Date

October 5, 2026

Dividend Yield

1.7%

Current income yield reference.

Payout Ratio

37.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Utah Medical Products Inc (NASDAQ-UTMD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Utah Medical Products Inc (NASDAQ-UTMD) Stock Forecast & Technical Outlook

Review Utah Medical Products Inc (NASDAQ-UTMD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Utah Medical Products Inc (NASDAQ-UTMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Utah Medical Products Inc (NASDAQ-UTMD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Utah Medical Products Inc (NASDAQ-UTMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Utah Medical Products Inc (NASDAQ-UTMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Utah Medical Products Inc (NASDAQ-UTMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Utah Medical Products Inc (NASDAQ-UTMD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Utah Medical Products Inc (NASDAQ-UTMD) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Utah Medical Products Inc (NASDAQ-UTMD) Stock FAQ

Data-supported answers about Utah Medical Products Inc (NASDAQ-UTMD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$77.22
Estimated upside 4.4%
Valuation Rating
Undervalued
Estimated upside of 4.4%
Financial Health
Great
Current financial-health read

The current fair value estimate for Utah Medical Products Inc (NASDAQ-UTMD) is $77.22. This implies an estimated upside of 4.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 4.4% versus the current market price.

The current financial health read for Utah Medical Products Inc (NASDAQ-UTMD) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Utah Medical Products Inc (NASDAQ-UTMD) is October 23, 2026.

Based on the current data, dividend yield is 1.7%, payment date is October 5, 2026.

The current P/E ratio listed for Utah Medical Products Inc (NASDAQ-UTMD) is 22.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Utah Medical Products Inc is 235.4 M.

The current enterprise value listed for Utah Medical Products Inc is 148.9 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Utah Medical Products Inc is NASDAQ-UTMD, and the stock is listed on NASDAQ.

Utah Medical Products Inc (NASDAQ-UTMD) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Utah Medical Products Inc is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Utah Medical Products Inc is 87.3%. Free float helps investors understand how much of the share base is available for public trading.